Skip to content

Clinical trials

Epilepsies, Partial trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20071
20121
20132
20161
20202
20211
20221
20231
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated3
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
SK Life Science, Inc.3
AbbVie2
Biohaven Therapeutics Ltd.2
Pfizer2
Shanghai Zhimeng Biopharma, Inc.2
Cerebral Therapeutics LLC1
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Marinus Pharmaceuticals1
NYU Langone Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial19
Seizures10
Epilepsy8
Drug Resistant Epilepsy2
Lennox Gastaut Syndrome1
Malformations of Cortical Development1
Periventricular Nodular Heterotopia1
Polymicrogyria1
Spasms, Infantile1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.